01 253BOEHRINGER INGELHEIM
01 510022379*PED
02 110034877*PED
03 610258637*PED
04 310973827*PED
05 311033552*PED
06 611090323*PED
07 127407955
08 127407955*PED
09 67579449
10 67579449*PED
11 67713938
12 67713938*PED
13 68551957
14 68551957*PED
15 88673927
16 88673927*PED
17 48846695
18 48846695*PED
19 18853156
20 18853156*PED
21 128883805
22 128883805*PED
23 99155705
24 59155705*PED
25 49173859
26 29173859*PED
27 99415016
28 910022379
29 110034877
30 610258637
31 410406172
32 810596120
33 310973827
34 311033552
35 611090323
36 311564886
37 1211833166
38 611911388
39 612115179
40 59415016*PED
41 19486526
42 19486526*PED
43 49555001
44 29555001*PED
45 69949998
46 49949998*PED
01 24Y
02 229Blank
01 88Y
02 165Blank
01 122025-05-02
02 122025-11-02
03 122025-11-26
04 122026-05-26
05 62027-04-15
06 152027-05-04
07 62027-10-15
08 132027-11-04
09 62028-08-01
10 62029-02-01
11 212029-04-02
12 22029-08-05
13 132029-10-02
14 62029-10-14
15 22030-02-05
16 62030-02-11
17 62030-04-10
18 62030-04-14
19 92030-05-21
20 42030-06-04
21 42030-06-15
22 52030-11-21
23 42030-12-04
24 12031-03-05
25 12031-09-05
26 112032-03-07
27 42033-03-06
28 22033-09-06
29 242034-04-03
30 62034-06-11
31 122034-10-03
32 42034-12-11
Patent Expiration Date : 2027-05-04
US Patent Number : 9173859
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 206073
Patent Use Code : U-1772
Delist Requested : Y
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2027-05-04
Patent Expiration Date : 2031-03-05
US Patent Number : 8853156
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 201280
Patent Use Code : U-1642
Delist Requested :
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2031-03-05
Patent Expiration Date : 2027-05-04
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8673927
Drug Substance Claim :
Drug Product Claim :
Application Number : 201281
Patent Use Code : U-1503
Delist Requested : Y
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2027-05-04
Patent Expiration Date : 2027-05-04
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8673927
Drug Substance Claim :
Drug Product Claim :
Application Number : 201281
Patent Use Code : U-1503
Delist Requested : Y
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2027-05-04
Patent Expiration Date : 2027-05-04
US Patent Number : 8673927
Drug Substance Claim :
Drug Product Claim :
Application Number : 201280
Patent Use Code : U-1503
Delist Requested : Y
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2027-05-04
Patent Expiration Date : 2027-05-04
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 9173859
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208026
Patent Use Code : U-1503
Delist Requested : Y
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2027-05-04
Patent Expiration Date : 2033-03-06
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 9555001
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208026
Patent Use Code : U-1967
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-03-06
Patent Expiration Date : 2033-03-06
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 9555001
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208026
Patent Use Code : U-1968
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-03-06
Patent Expiration Date : 2029-10-14
US Patent Number : 8551957
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 206073
Patent Use Code : U-1651
Delist Requested :
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2029-10-14
Patent Expiration Date : 2030-06-04
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8846695
Drug Substance Claim :
Drug Product Claim :
Application Number : 201281
Patent Use Code : U-1503
Delist Requested :
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2030-06-04
LOOKING FOR A SUPPLIER?
